Data Holes Could Complicate Moderna and J&J Booster Shot Process

October 1, 2021

(Axios) – Deciding which Moderna and Johnson & Johnson coronavirus vaccine recipients should get booster shots may end up being even messier than the process for Pfizer recipients was. Why it matters: More Americans may very well need another round of shots, particularly older people and those who received J&J’s one-dose vaccine. But regulators had issues with the quantity of data available for boosting with Pfizer, and there’s even less — at least publicly available at this time — for the other two vaccines. The big picture: The U.S. has relied heavily on other countries’ data when it comes to making booster decisions, particularly Israel. (Read Full Article)